Cell line · CVCL_0292
HCT 15
Cancer cell line, Homo sapiens. Colon adenocarcinoma. 125 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. HCT 15. Cell lines, record CVCL_0292. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0292
On this page
Cell line
As Cellosaurus gives it.
- Name
- HCT 15
- Accession
- CVCL_0292
- RRID
- RRID:CVCL_0292
- Synonyms
- HCT-15, HCT.15, HCT15
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 67Y
- Category
- Cancer cell line
- Diseases
- Colon adenocarcinoma (NCIt C4349)
- Derived from
- Colon (in situ)
- Cell type
- Epithelial cell of colon
- Parent
- __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18 (CVCL_3449)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers125
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| PubMed 43000531 | Nat Commun | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Integrative genomics and experimental validation identify a mechanosensitive gene signature associated with colorectal cancer liver metastasis. | iScience | 2026 | Its Methods give the RRID and name the line | PubMed | |
| MZF1 Inhibits TGFβ-1/SMAD Signaling by Transcriptionally Activating SnoN to Augment Tumorigenic Potential in Colon Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Allele-Specific Mechanisms Guide Salvage Therapy to Overcome Daraxonrasib Resistance in Pancreatic Cancer. | Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A Novel tRNA Half mt-5'-tiRNA-Tyr Promotes Colorectal Cancer Proliferation via Inducing HARS2 Succinylation. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Selenium Nanoparticles Selectively Target KRAS G13D to Inhibit Colorectal Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Overcoming Daraxonrasib Resistance: Allele-Specific Mechanisms Guide Salvage Therapy in Pancreatic Cancer. | bioRxiv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| LncRNA AK093407-IFITM1- Wnt/β-catenin regulation axis in colorectal cancer. | Sci Prog | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Inhibition of cyclin-dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Cholesterol Reprograms Oxysterol Metabolism via the LOX1/CH25H/CYP7B1 Signaling Axis to Drive Multidrug Resistance in Colorectal Cancer. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 125
See all 125 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18 | CVCL_3449 | Cell lines | |
| Derived from it | HCT 15-Luc#1 | CVCL_4Y02 | Cell lines | |
| Derived from it | HCT-15-Luc2 | CVCL_A4BZ | Cell lines | |
| Derived from it | HyCyte HCT 15 KO-hARG1 | CVCL_F1P7 | Cell lines | |
| Derived from it | HyCyte HCT 15 KO-hBRCA2 | CVCL_E1K5 | Cell lines | |
| Derived from it | HyCyte HCT 15 KO-hDCBLD1 | CVCL_F4J9 | Cell lines | |
| Derived from it | HyCyte HCT 15-Luc | CVCL_E3HC | Cell lines | |
| Derived from it | OS 187 | CVCL_1R50 | Has a recorded problem | Cell lines |
Cell banks14
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ABM | T8966 | ABM | |
| ATCC | CCL-225 | ATCC | |
| AddexBio | C0009010/381 | Cellosaurus | |
| BCRC | 60539 | BCRC | |
| CCTCC | GDC0250 | Cellosaurus | |
| CLS | 300229 | CLS | |
| DSMZ | ACC-357 | DSMZ | |
| ECACC | 91030712 | ECACC | |
| ICLC | HTL00001 | ICLC | |
| KCB | KCB 2011097YJ | Cellosaurus |
1 to 10 of 14
See all 14 cell banksData dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0292
GET https://conductscience.org/api/cell-lines/v1/CVCL_0292/papers?page=2